First published 9/30/2026, 8:01:15 AM · Last updated 9/30/2026, 8:01:15 AM

Einfluss spezifischer Systemtherapien von neuroendokrinen Neoplasien auf Somatostatinrezeptor-Expression und Funktion in neuroendokrinen Tumorzellen

Journal article published 2026-08-01 by Georg Thieme Verlag KG examining how systemic therapies for neuroendocrine neoplasms affect somatostatin receptor expression and function in neuroendocrine tumor cells. The supplied excerpt contains only bibliographic metadata and does not include study methods, results, or conclusions.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 2/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The paper addresses therapy-related changes in somatostatin receptor expression and function in neuroendocrine tumor cells, which is relevant to clinical and research audiences.

Sources

Einfluss spezifischer Systemtherapien von neuroendokrinen Neoplasien auf Somatostatinrezeptor-Expression und Funktion in neuroendokrinen Tumorzellen

Report an issue